Presentation Information
[3PS-14-01]The LSD1 inhibitor, TAS1440 suppresses neuroendocrine small cell lung cancer growth by activating TGF-β and NOTCH signaling via LSD1-INSM1 complex disruption
○Tomoaki Tanaka1, Shuichi Ohkubo2 (1. Chiba University Graduate School of Medicine , 2. Taiho Pharmaceutical Co., Ltd.)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in